Hormonal therapy

Some breast cancers are caused due to the hormones in blood. It is a form of systemic therapy it not only reaches the cancer cells present in breast also reaches cancer cells all over the body. Hormonal therapy is recommended for women with hormone receptor-positive breast cancers, it is not useful for the women who are suffering with hormone receptor-negative breast cancer.

Hormonal therapy is often used as adjuvant therapy to reduce the risk of cancer coming back. Sometimes this therapy is started as neoadjuvant therapy. The drugs that stop estrogen from affecting breast cancer cells are,

  • ER-positive cancers
  • PR-positive cancers
  • Adjuvant therapy
  • Neo-adjuvant therapy
  • Breast cancer hormone therapy
  • Prostate cancer hormone therapy
  • Womb cancer hormone therapy

Related Conference of Hormonal therapy

November 19-20, 2026

44th World Cancer Conference

Dubai, UAE
November 23-24, 2026

8th International Conference on Women Oncology

Miami, USA
November 23-24, 2026

7th Cancer Diagnostics & Treatment Conference

Miami, USA
November 24-25, 2026

6th International Conference on Oncology and Cancer

Paris, France
December 03-04, 2026

10th Global Meeting on Oncology and Radiology

Madrid, Spain
December 08-09, 2026

27th World Congress on Cancer Summit

Paris, France
December 08-09, 2026

14th Euro Breast Cancer and Therapeutics

Paris, France
February 15-16, 2027

5th World Congress on Oral Cancer

Singapore City, Singapore
April 15-16, 2027

12th World Conference on Breast and Cervical Cancer

Amsterdam, Netherlands
April 26-27, 2027

26th World Congress on Cancer and Diagnostics

Barcelona, Spain
April 27-28, 2027

37th Experts Meet On Cancer Research & Therapy

Paris, France
May 05-06, 2027

7th World Congress on Breast Cancer

Berlin, Germany
May 05-06, 2027

23rd International Conference on Cancer Research

Berlin, Germany

Hormonal therapy Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in